These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36282782)

  • 1. Neuroleptic Sensitivity in Dementia with Lewy Body and Use of Pimavanserin in an Inpatient Setting: A Case Report.
    Abadir A; Dalton R; Zheng W; Pincavitch J; Tripathi R
    Am J Case Rep; 2022 Oct; 23():e937397. PubMed ID: 36282782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series.
    Rothenberg KG; McRae SG; Dominguez-Colman LM; Shutes-David A; Tsuang DW
    Am J Case Rep; 2023 Sep; 24():e939806. PubMed ID: 37775968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Horn S; Richardson H; Xie SX; Weintraub D; Dahodwala N
    Parkinsonism Relat Disord; 2019 Dec; 69():119-124. PubMed ID: 31751863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
    Fernandez HH; Trieschmann ME; Burke MA; Friedman JH
    J Clin Psychiatry; 2002 Jun; 63(6):513-5. PubMed ID: 12088163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with lewy bodies: therapeutic opportunities and pitfalls.
    Henriksen AL; St Dennis C; Setter SM; Tran JT
    Consult Pharm; 2006 Jul; 21(7):563-75. PubMed ID: 16934009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psychosis in Parkinson's disease and dementia with Lewy Bodies: A review.
    Kyle K; Bronstein JM
    Parkinsonism Relat Disord; 2020 Jun; 75():55-62. PubMed ID: 32480308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of dementia with Lewy bodies.
    Fernandez HH; Wu CK; Ott BR
    Expert Opin Pharmacother; 2003 Nov; 4(11):2027-37. PubMed ID: 14596656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pimavanserin and trazodone combination in behavioral disorders in severe dementia with Lewy bodies].
    Muller C; Merignac J; Moog C; Schorr B; Javelot H; Blanc F
    Geriatr Psychol Neuropsychiatr Vieil; 2023 Mar; 21(1):116-127. PubMed ID: 37115687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis Management in Lewy Body Dementia: A Comprehensive Clinical Approach.
    Badwal K; Kiliaki SA; Dugani SB; Pagali SR
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):255-261. PubMed ID: 33461372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease.
    Younce JR; Davis AA; Black KJ
    J Parkinsons Dis; 2019; 9(1):63-71. PubMed ID: 30475775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with pimavanserin of Lewy body dementia related psychosis with previous clozapine intolerance - A case report.
    Nizon D; Abdel Ahad P; Chauviré V; Godier E; Gohier B; Kazour F
    Encephale; 2024 Jun; 50(3):358-359. PubMed ID: 38311485
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological Management of Dementia with Lewy Bodies.
    Hershey LA; Coleman-Jackson R
    Drugs Aging; 2019 Apr; 36(4):309-319. PubMed ID: 30680679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of persistent distressing neuropsychiatric symptoms by clozapine in a patient suffering from dementia with Lewy bodies.
    Bhamra M; Rajkumar AP; Ffytche DH; Kalafatis C
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
    Cummings JL; Street J; Masterman D; Clark WS
    Dement Geriatr Cogn Disord; 2002; 13(2):67-73. PubMed ID: 11844887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
    Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
    Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for psychosis in Parkinson's disease patients.
    Friedman JH
    Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome.
    Majic T; Mell T; Heinz A; Rapp MA
    Int Psychogeriatr; 2010 Jun; 22(4):678-9. PubMed ID: 20199702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.